Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Disruption of postsynaptic signaling by CNV WP4875,3.881837377933528e-06,9.165364583333334,114.19312843032182,"['TJP1', 'RYR2', 'CAMK2D', 'DLG1', 'ARC', 'DLG2', 'HOMER1', 'NRXN3', 'DLGAP1']",0.0014750982036147405,0,0,9
2,Fragile X Syndrome  WP4549,0.00020764593511571209,3.3652690498265856,28.536391746358994,"['NTRK2', 'HOMER1', 'KCND2', 'ITPR1', 'GAB1', 'BRAF', 'GRIP1', 'ARHGAP32', 'PPP3CA', 'ARC', 'GRM5', 'NF1', 'PLCB1', 'HCN1']",0.039452727671985294,0,0,14
3,MAPK Signaling Pathway WP382,0.0006642889450435618,2.4711331725466,18.080770751358266,"['NTRK2', 'DUSP1', 'BRAF', 'FOS', 'HSPA2', 'NFKB1', 'MAPK10', 'PPP3CA', 'NR4A1', 'CACNB4', 'RAP1A', 'RASA1', 'AKT3', 'NF1', 'RAPGEF2', 'TAB2', 'FGF12', 'MAP4K3', 'FGFR2']",0.0576350564170503,0,0,19
4,Melanoma WP4685,0.0008222718436337701,4.064814814814815,28.874166146486374,"['CDK6', 'PIK3CA', 'ERBB4', 'AKT3', 'NF1', 'MITF', 'BRAF', 'FOS', 'VCL']",0.0576350564170503,0,0,9
5,Ras signaling WP4223,0.0008325918827756096,2.76394934705184,19.59907353360624,"['NTRK2', 'GAB1', 'RASAL2', 'NFKB1', 'IGF1R', 'MAPK10', 'AFDN', 'RAP1A', 'PIK3CA', 'RASA1', 'AKT3', 'NF1', 'RGL1', 'FGFR2', 'EXOC2']",0.0576350564170503,0,0,15
6,Splicing factor NOVA regulated synaptic proteins WP4148,0.0009100272065850047,5.1632064590542095,36.15295781954681,"['NTNG1', 'CDH2', 'CADM1', 'EPB41', 'EPB41L3', 'ANK3', 'EFNA5']",0.0576350564170503,0,0,7
7,Head and Neck Squamous Cell Carcinoma WP4674,0.0012904107077832297,3.783405172413793,25.170218004420505,"['CDK6', 'PIK3CA', 'SESN1', 'AKT3', 'GAB1', 'RICTOR', 'NFKB1', 'FGFR2', 'IGF1R']",0.07005086699394675,0,0,9
8,Signaling of Hepatocyte Growth Factor Receptor WP313,0.0020193414897241085,5.208734270910437,32.320111852339046,"['RAP1A', 'PIK3CA', 'RASA1', 'PXN', 'GAB1', 'FOS']",0.0768072706425685,0,0,6
9,Focal Adhesion WP306,0.0022016622155519444,2.481152204836415,15.181035589858059,"['VAV3', 'ROCK2', 'PXN', 'BRAF', 'LAMC1', 'IGF1R', 'MAPK10', 'RAP1A', 'COL4A2', 'PIK3CA', 'COL4A1', 'ITGA10', 'AKT3', 'PDGFC', 'VCL']",0.0768072706425685,0,0,15
10,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.00239386781962408,8.819277108433734,53.222969360989346,"['TJP1', 'PXN', 'ITPR1', 'VCL']",0.0768072706425685,0,0,4
11,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.002608819074933226,3.374278846153846,20.07310443185423,"['RPS6KA6', 'TBC1D4', 'PIK3CA', 'AKT3', 'ZNF516', 'PPARG', 'PLCB1', 'ADCY8', 'MAP4K5']",0.0768072706425685,0,0,9
12,Rett syndrome causing genes WP4312,0.0027313325202729757,4.153388471600979,24.51730962933807,"['CDKL5', 'SCN8A', 'BRAF', 'HIVEP2', 'SMARCA1', 'SCN2A', 'SCN1A']",0.0768072706425685,0,0,7
13,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.002852336333970876,2.604321907600596,15.260328543593142,"['VAV3', 'EGR1', 'NTRK2', 'CDKL5', 'FOS', 'ACACB', 'NFKB1', 'MAPK10', 'GRIP1', 'DLG1', 'RAP1A', 'CDH2', 'KCNN2']",0.0768072706425685,0,0,13
14,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.003066750139794867,3.6069067334231977,20.87366292368897,"['EGR1', 'RAP1A', 'PIK3CA', 'PDE4D', 'BRAF', 'FOS', 'PLCB1', 'IGF1R']",0.0768072706425685,0,0,8
15,miRNA targets in ECM and membrane receptors WP2911,0.0030922953361105657,8.083763625932301,46.71478982206573,"['COL4A2', 'COL4A1', 'SDC2', 'LAMC1']",0.0768072706425685,0,0,4
16,Resistin as a regulator of inflammation WP4481,0.0032339903428449893,5.780377668308703,33.14490811754127,"['PIK3CA', 'AKT3', 'ITPR1', 'PLCB1', 'NFKB1']",0.0768072706425685,0,0,5
17,Ciliopathies WP4803,0.004287059762265,2.376581046896283,12.957486220301714,"['DYNC2H1', 'C2CD3', 'ARL6', 'WDR19', 'LCA5', 'GLI3', 'TTLL5', 'NME7', 'CSPP1', 'TTC21B', 'BBS9', 'RAB28', 'IFT57', 'DNAI1']",0.09582839468592351,0,0,14
18,Integrin-mediated Cell Adhesion WP185,0.0056637319530433395,2.9619932432432434,15.324382242471797,"['VAV3', 'MAPK10', 'RAP1A', 'ROCK2', 'ITGA10', 'AKT3', 'PXN', 'BRAF', 'VCL']",0.10697846312800126,0,0,9
19,Ectoderm Differentiation WP2858,0.005748084109180466,2.604597273434593,13.436827384929758,"['PLCXD3', 'SMURF1', 'CTNND2', 'ZNF219', 'ST8SIA4', 'LDB2', 'PTPN13', 'FGFR2', 'GLI3', 'ANKS1B', 'WDR44']",0.10697846312800126,0,0,11
20,Insulin Signaling WP481,0.006238115428315843,2.3513468013468013,11.937969133089823,"['EGR1', 'STXBP4', 'GAB1', 'CBLB', 'FOS', 'IGF1R', 'GYS2', 'MAPK10', 'RPS6KA6', 'TBC1D4', 'PIK3CA', 'MAP4K5', 'MAP4K3']",0.10697846312800126,0,0,13
21,BDNF-TrkB Signaling WP3676,0.007093620661811495,4.66710875331565,23.095464878801177,"['NTRK2', 'ARC', 'HOMER1', 'GAB1', 'BRAF']",0.10697846312800126,0,0,5
22,Neural Crest Cell Migration in Cancer WP4565,0.007093620661811495,4.66710875331565,23.095464878801177,"['NTRK2', 'TRIO', 'PIK3CA', 'AKT3', 'FOS']",0.10697846312800126,0,0,5
23,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.007255601229885499,6.061101549053356,29.856874251616155,"['PPP3CA', 'RASA1', 'DYRK1A', 'NFKB1']",0.10697846312800126,0,0,4
24,EGF/EGFR signaling pathway WP437,0.007353998039232963,2.2997364953886694,11.297481204932144,"['VAV3', 'NCOA3', 'GAB1', 'CBLB', 'BRAF', 'ASAP1', 'FOS', 'PTPN12', 'RAP1A', 'RASA1', 'FOSB', 'RICTOR', 'SH3GL2']",0.10697846312800126,0,0,13
25,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.0076850301943460755,3.0411611785095323,14.805835333405264,"['PPP3CA', 'CAMK2D', 'PIK3CA', 'ROCK2', 'PRKG1', 'NFKB1', 'FGFR2', 'IGF1R']",0.10697846312800126,0,0,8
26,ErbB signaling pathway WP673,0.007688108170647019,2.809294871794872,13.67587368906116,"['MAPK10', 'CAMK2D', 'NRG3', 'PIK3CA', 'ERBB4', 'AKT3', 'GAB1', 'CBLB', 'BRAF']",0.10697846312800126,0,0,9
27,Serotonin and anxiety-related events WP3944,0.008164145870294832,9.081185567010309,43.66236896349525,"['PPP3CA', 'ARC', 'FOS']",0.10697846312800126,0,0,3
28,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.008164145870294832,9.081185567010309,43.66236896349525,"['GALNT3', 'NFKB1', 'FGFR2']",0.10697846312800126,0,0,3
29,RAS and bradykinin pathways in COVID-19 WP4969,0.008164145870294832,9.081185567010309,43.66236896349525,"['KLKB1', 'PRKG1', 'NFKB1']",0.10697846312800126,0,0,3
30,PKC-gamma calcium signaling pathway in ataxia WP4760,0.008685353631518164,5.704161182545307,27.07261728679755,"['ITPR1', 'CA8', 'PLCB1', 'GRIA4']",0.1100144793325634,0,0,4
31,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.010287318761282496,5.386880856760375,24.654909721496505,"['ADAMTS2', 'BMP1', 'ITPR1', 'PLOD2']",0.1115429844175083,0,0,4
32,Estrogen signaling pathway WP712,0.010287318761282496,5.386880856760375,24.654909721496505,"['PIK3CA', 'BRAF', 'FOS', 'NFKB1']",0.1115429844175083,0,0,4
33,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.010431781296148617,3.5538986477947683,16.21607788063802,"['NTRK2', 'ARC', 'PIK3CA', 'HOMER1', 'AKT3', 'NF1']",0.1115429844175083,0,0,6
34,Endochondral Ossification with Skeletal Dysplasias WP4808,0.010431781296148617,3.5538986477947683,16.21607788063802,"['GHR', 'SOX6', 'SLC38A2', 'GLI3', 'RUNX2', 'IGF1R']",0.1115429844175083,0,0,6
35,Endochondral Ossification WP474,0.010431781296148617,3.5538986477947683,16.21607788063802,"['GHR', 'SOX6', 'SLC38A2', 'GLI3', 'RUNX2', 'IGF1R']",0.1115429844175083,0,0,6
36,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.010567230102711314,8.071592210767468,36.725724914071805,"['RYR2', 'ITPR1', 'PLCB1']",0.1115429844175083,0,0,3
37,Glioblastoma signaling pathways WP2261,0.011376532813368031,2.8197824831085323,12.62191759885904,"['CDK6', 'PIK3CA', 'AKT3', 'GAB1', 'NF1', 'BRAF', 'FGFR2', 'IGF1R']",0.11684006673188789,0,0,8
38,Cell migration and invasion through p75NTR WP4561,0.012068738769765792,5.102998460005435,22.54064199363941,"['NTRK2', 'TRIO', 'AKT3', 'EFNA5']",0.1200643269644169,0,0,4
39,Chemokine signaling pathway WP3929,0.01232239145161121,2.4351304347826086,10.705654586400465,"['VAV3', 'RAP1A', 'PIK3CA', 'ROCK2', 'AKT3', 'PXN', 'BRAF', 'PLCB1', 'ADCY8', 'NFKB1']",0.1200643269644169,0,0,10
40,PI3K-Akt signaling pathway WP4172,0.0135913548932091,1.897316547687954,8.15527623977734,"['NTRK2', 'LAMC1', 'EFNA5', 'NFKB1', 'IGF1R', 'GYS2', 'GHR', 'CDK6', 'COL4A2', 'PIK3CA', 'COL4A1', 'PPP2R2B', 'ITGA10', 'AKT3', 'PDGFC', 'FGF12', 'FGFR2']",0.12793356159019845,0,0,17
41,Cardiac Hypertrophic Response WP2795,0.013972744639808339,3.3108808290155443,14.139602148496728,"['PPP3CA', 'CAMK2D', 'PRKD1', 'PRKG1', 'NFKB1', 'FGFR2']",0.12793356159019845,0,0,6
42,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.014140025228390356,2.7017138455613328,11.505912585334064,"['PIK3CA', 'AKT3', 'PDGFC', 'GAB1', 'NF1', 'BRAF', 'FGFR2', 'IGF1R']",0.12793356159019845,0,0,8
43,Oxidative Stress WP408,0.016195642285911565,4.616342922711254,19.033242194982126,"['MAPK10', 'FOS', 'JUNB', 'NFKB1']",0.1391611992218202,0,0,4
44,Pathways Regulating Hippo Signaling WP4540,0.016235135244555138,2.6283198276265867,10.830195657620019,"['NTRK2', 'GNAL', 'CDH2', 'PLCB1', 'TEAD1', 'FGFR2', 'CDH18', 'IGF1R']",0.1391611992218202,0,0,8
45,Serotonin and anxiety WP3947,0.016479615697320812,6.603092783505154,27.109862917190526,"['PPP3CA', 'ARC', 'FOS']",0.1391611992218202,0,0,3
46,Pilocytic astrocytoma WP2253,0.021353089497716193,12.090909090909092,46.508393278994326,"['NF1', 'BRAF']",0.17464478688637364,0,0,2
47,Oncostatin M Signaling Pathway WP2374,0.02160080258857779,2.97197842867717,11.397611003126048,"['EGR1', 'PXN', 'RICTOR', 'FOS', 'JUNB', 'NFKB1']",0.17464478688637364,0,0,6
48,Neural Crest Cell Migration during Development WP4564,0.023875026036501882,4.038439472174412,15.083257650231776,"['TRIO', 'PIK3CA', 'AKT3', 'FOS']",0.18537091717177664,0,0,4
49,Pregnane X receptor pathway WP2876,0.023903091951097515,5.586439333862014,20.858353662489026,"['NCOA1', 'NCOA2', 'NCOA3']",0.18537091717177664,0,0,3
50,Regulation of Actin Cytoskeleton WP51,0.027628435514881988,2.11523629489603,7.591392192653393,"['DIAPH3', 'PIK3CA', 'ROCK2', 'PXN', 'BRAF', 'SSH2', 'FGF12', 'VCL', 'FGFR2', 'ARHGEF6']",0.2099761099131031,0,0,10
51,VEGFA-VEGFR2 Signaling Pathway WP3888,0.029237451256652586,1.584787729938349,5.597953327985805,"['EGR1', 'EGR3', 'ROCK2', 'EPB41', 'FHOD1', 'PXN', 'GAB1', 'LDB2', 'ACACB', 'SND1', 'NFKB1', 'QKI', 'PPP3CA', 'AFDN', 'NR4A1', 'RAP1A', 'PIK3CA', 'KATNAL2', 'RICTOR', 'PRKD1', 'ASCC3', 'PRKG1', 'VCL']",0.21346300335026594,0,0,23
52,Corticotropin-releasing hormone signaling pathway WP2355,0.029503369267062273,2.499440260533279,8.80615492175894,"['NCOA2', 'NR4A1', 'FOSB', 'BRAF', 'FOS', 'JUNB', 'NFKB1']",0.21346300335026594,0,0,7
53,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.029772471519905513,3.108532272325376,10.923914234142455,"['TGFBR3', 'FOS', 'RUNX2', 'NFKB1', 'FBN1']",0.21346300335026594,0,0,5
54,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.03243672935376461,3.030603448275862,10.390314445556534,"['MAPK10', 'TAB2', 'IL1RAP', 'FOS', 'NFKB1']",0.21897776026823154,0,0,5
55,Vitamin D in inflammatory diseases WP4482,0.03284666404023473,4.840893470790378,16.53603264941595,"['PPP3CA', 'DUSP1', 'NFKB1']",0.21897776026823154,0,0,3
56,Hippo-Yap signaling pathway WP4537,0.03284666404023473,4.840893470790378,16.53603264941595,"['TNIK', 'TEAD1', 'MAP4K3']",0.21897776026823154,0,0,3
57,"Relationship between inflammation, COX-2 and EGFR WP4483",0.03284666404023473,4.840893470790378,16.53603264941595,"['PIK3CA', 'AKT3', 'BRAF']",0.21897776026823154,0,0,3
58,Toll-like Receptor Signaling Pathway WP75,0.036378698114784655,2.5991857883049594,8.61310880807866,"['MAPK10', 'PIK3CA', 'AKT3', 'TAB2', 'FOS', 'NFKB1']",0.22750103389136264,0,0,6
59,Development of ureteric collection system WP5053,0.03704496172541129,3.4605360216375707,11.404621836373732,"['GRIP1', 'SLIT2', 'GLI3', 'FGFR2']",0.22750103389136264,0,0,4
60,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.03704496172541129,3.4605360216375707,11.404621836373732,"['NTRK2', 'GABRB1', 'PIK3CA', 'GABRA4']",0.22750103389136264,0,0,4
61,Spinal Cord Injury WP2431,0.03769232265884818,2.3599096501345636,7.736489088051729,"['EGR1', 'NR4A1', 'PPP3CA', 'COL4A1', 'ROCK2', 'FOS', 'SLIT2']",0.22750103389136264,0,0,7
62,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.03788226184738937,4.538015463917525,14.854160322212676,"['EGR1', 'RAP1A', 'BRAF']",0.22750103389136264,0,0,3
63,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.03788226184738937,4.538015463917525,14.854160322212676,"['SGPL1', 'GALNT1', 'SGPP2']",0.22750103389136264,0,0,3
64,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.03831596360275581,1.7241807348560079,5.624085596101647,"['CAB39L', 'LAMC1', 'EFNA5', 'IGF1R', 'GYS2', 'GHR', 'COL4A2', 'PIK3CA', 'COL4A1', 'PPP2R2B', 'ITGA10', 'AKT3', 'PDGFC', 'FGF12', 'FGFR2']",0.22750103389136264,0,0,15
65,Circadian rhythm related genes WP3594,0.04066794101828148,1.897484369980478,6.076343014880297,"['MAPK10', 'EGR1', 'NCOA2', 'EGR3', 'HOMER1', 'KCND2', 'PSPC1', 'ROCK2', 'DYRK1A', 'CRY1', 'PPARG']",0.23775103979918402,0,0,11
66,Breast cancer pathway WP4262,0.04396289151269652,2.0245949074074074,6.325663310527819,"['NCOA1', 'MRE11', 'CDK6', 'PIK3CA', 'NCOA3', 'AKT3', 'BRAF', 'FOS', 'IGF1R']",0.2531196784064345,0,0,9
67,G Protein Signaling Pathways WP35,0.044728033325617325,2.265028835063437,7.037795285376218,"['PPP3CA', 'GNAL', 'PDE4D', 'ITPR1', 'AKAP6', 'PRKD1', 'ADCY8']",0.2536813830408147,0,0,7
68,Gastrin signaling pathway WP4659,0.045968140751945157,2.1113706578253333,6.502613529391472,"['TJP1', 'EGR1', 'PIK3CA', 'PXN', 'PPARG', 'PRKD1', 'FOS', 'NFKB1']",0.25688078655498764,0,0,8
69,Pancreatic adenocarcinoma pathway WP4263,0.04724852189461259,2.235066472409397,6.82216918078353,"['MAPK10', 'CDK6', 'PIK3CA', 'AKT3', 'BRAF', 'NFKB1', 'ARHGEF6']",0.26020925101380843,0,0,7
70,Genes related to primary cilium development (based on CRISPR) WP4536,0.048265295642229054,2.0885186634613593,6.330388817010906,"['DYNC2H1', 'C2CD3', 'ARL6', 'TTC21B', 'WDR19', 'BBS9', 'KIFAP3', 'IFT57']",0.26201160491495773,0,0,8
71,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.0490539193921419,4.033218785796105,12.159489924811243,"['TGFBR3', 'RUNX2', 'FBN1']",0.26254210378892845,0,0,3
72,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.0501451654511109,2.385288371697953,7.138770161202962,"['MAPK10', 'DCC', 'AKT3', 'BRAF', 'FOS', 'EXOC2']",0.2646550398808631,0,0,6
73,Apoptosis Modulation and Signaling WP1772,0.05323353963476786,2.346648838375397,6.882877416637055,"['TNFRSF6B', 'BIRC6', 'FOS', 'PRKD1', 'PTPN13', 'NFKB1']",0.2771060967289286,0,0,6
74,Physiological and pathological hypertrophy of the heart WP1528,0.05517496925279726,3.8206728160607706,11.069428590849352,"['PPP3CA', 'CAMK2D', 'FOS']",0.28063956383983507,0,0,3
75,TCA cycle in senescence WP5050,0.05765895731480829,6.043739279588336,17.24405535712444,"['ME1', 'BRAF']",0.28063956383983507,0,0,2
76,Small cell lung cancer WP4658,0.05822500037480767,2.122707612456747,6.035792703162729,"['CDK6', 'PIK3CA', 'COL4A2', 'COL4A1', 'AKT3', 'LAMC1', 'NFKB1']",0.28063956383983507,0,0,7
77,Osteoblast differentiation WP4787,0.05822500037480767,2.122707612456747,6.035792703162729,"['MAPK10', 'PIK3CA', 'PPARG', 'PRKD1', 'RUNX2', 'FGFR2', 'GLI3']",0.28063956383983507,0,0,7
78,Regulation of toll-like receptor signaling pathway WP1449,0.05822500037480767,2.122707612456747,6.035792703162729,"['MAPK10', 'PIK3CA', 'AKT3', 'TAB2', 'FOS', 'CTNNAL1', 'NFKB1']",0.28063956383983507,0,0,7
79,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.05834348827196571,2.9351692484222607,8.340011987312788,"['MAPK10', 'MAP4K5', 'TEAD1', 'MAP4K3']",0.28063956383983507,0,0,4
80,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.06164091124723801,3.629381443298969,10.11301546687988,"['PIK3CA', 'CBLB', 'NFKB1']",0.29068847035675766,0,0,3
81,Myometrial relaxation and contraction pathways WP289,0.06196254236551939,1.8838900862068966,5.239522641898647,"['RYR2', 'CAMK2D', 'PDE4D', 'ITPR1', 'PRKD1', 'FOS', 'ADCY8', 'NFKB1', 'RGS7']",0.29068847035675766,0,0,9
82,Mesodermal commitment pathway WP2857,0.06360764438555745,1.9611014827652609,5.402876986223687,"['VAV3', 'SESN1', 'UBR5', 'ARID5B', 'ASCC3', 'TOX', 'TRERF1', 'TEAD1']",0.2941867673206951,0,0,8
83,Hippo-Merlin Signaling Dysregulation WP4541,0.06425658338846761,2.0706388724786904,5.683636789800627,"['NTRK2', 'CDH2', 'ITGA10', 'TEAD1', 'FGFR2', 'CDH18', 'IGF1R']",0.2941867673206951,0,0,7
84,Common Pathways Underlying Drug Addiction WP2636,0.06835214364081091,2.7670518809933613,7.424228073389218,"['GRM5', 'RAP1A', 'ADCY8', 'GRIA4']",0.2964769468690333,0,0,4
85,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.06844159083409414,3.4563082965144822,9.269039751018429,"['NFKB1', 'RUNX2', 'FGFR2']",0.2964769468690333,0,0,3
86,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.06865781927493403,5.371831522774919,14.389096710850156,"['SMURF1', 'RUNX2']",0.2964769468690333,0,0,2
87,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.06865781927493403,5.371831522774919,14.389096710850156,"['NRG3', 'ERBB4']",0.2964769468690333,0,0,2
88,"NAD metabolism, sirtuins and aging WP3630",0.06865781927493403,5.371831522774919,14.389096710850156,"['PPARG', 'NFKB1']",0.2964769468690333,0,0,2
89,MET in type 1 papillary renal cell carcinoma WP4205,0.07146032655654183,2.3750845165652468,6.266928540959685,"['RAP1A', 'PIK3CA', 'AKT3', 'GAB1', 'BRAF']",0.3051115066459089,0,0,5
90,TGF-beta Receptor Signaling WP560,0.07366718140425396,2.689998087588449,7.016047305940436,"['TGFBR3', 'FOS', 'RUNX2', 'NFKB1']",0.31103921037351673,0,0,4
91,Sphingolipid pathway WP1422,0.07556604523378016,3.2989690721649483,8.52040654452205,"['SGPL1', 'SGPP2', 'PLPP1']",0.31555051855864247,0,0,3
92,Galanin receptor pathway WP4970,0.0802759508309723,4.834305317324185,12.193496727123106,"['PPARG', 'FOS']",0.32036458394471784,0,0,2
93,Hedgehog Signaling Pathway Netpath WP47,0.0802759508309723,4.834305317324185,12.193496727123106,"['STK36', 'GLI3']",0.32036458394471784,0,0,2
94,IL1 and megakaryocytes in obesity WP2865,0.0802759508309723,4.834305317324185,12.193496727123106,"['PIK3CA', 'NFKB1']",0.32036458394471784,0,0,2
95,Overview of nanoparticle effects WP3287,0.0802759508309723,4.834305317324185,12.193496727123106,"['COL4A1', 'AKT3']",0.32036458394471784,0,0,2
96,Thermogenesis WP4321,0.08093421068077082,1.95094061965557,4.904896232331509,"['RPS6KA6', 'ZNF516', 'PPARG', 'ADCY8', 'CPT1B', 'ARID1B', 'PRKG1']",0.32036458394471784,0,0,7
97,Genes controlling nephrogenesis WP4823,0.08300262582825886,3.155311519497983,7.853201311652553,"['SLIT2', 'GLI3', 'FGFR2']",0.3218469164769221,0,0,3
98,Nanoparticle-mediated activation of receptor signaling WP2643,0.08300262582825886,3.155311519497983,7.853201311652553,"['MAPK10', 'PXN', 'AKT3']",0.3218469164769221,0,0,3
99,AMP-activated protein kinase (AMPK) signaling WP1403,0.08520806637217877,2.2426564495530013,5.522898479394412,"['GYS2', 'PIK3CA', 'PLCB1', 'CPT1B', 'ACACB']",0.32379065221427933,0,0,5
100,Pathways affected in adenoid cystic carcinoma WP3651,0.08520806637217877,2.2426564495530013,5.522898479394412,"['MAGI1', 'PIK3CA', 'MAGI2', 'JMJD1C', 'ARID5B']",0.32379065221427933,0,0,5
101,Integrated breast cancer pathway WP1984,0.08713966361375058,1.747125,4.2634097585786686,"['FER', 'MRE11', 'RAP1A', 'RALGAPA1', 'ZMYND8', 'NCOA3', 'NF1', 'BRAF', 'NFKB1']",0.32785219973490315,0,0,9
102,Hepatitis B infection WP4666,0.09174132187617201,1.7965209576994672,4.291497610807946,"['MAPK10', 'EGR3', 'PIK3CA', 'AKT3', 'BRAF', 'TAB2', 'FOS', 'NFKB1']",0.3377862392930129,0,0,8
103,Airway smooth muscle cell contraction WP4962,0.09244676022756142,4.394511149228131,10.463868781865942,"['ROCK2', 'PLCB1']",0.3377862392930129,0,0,2
104,GPR40 Pathway WP3958,0.09244676022756142,4.394511149228131,10.463868781865942,"['PLCL1', 'PLCB1']",0.3377862392930129,0,0,2
105,Endometrial cancer WP4155,0.09508921894479613,2.1622536945812807,5.0876525190539335,"['PIK3CA', 'AKT3', 'BRAF', 'FOS', 'FGFR2']",0.3441324114192622,0,0,5
106,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.09692015527992633,2.4203098106712564,5.64868308689703,"['DLG1', 'PIK3CA', 'FOS', 'NFKB1']",0.34744961326766044,0,0,4
107,The influence of laminopathies on Wnt signaling WP4844,0.09876280655621703,2.9024742268041237,6.719327090858935,"['CDK6', 'PPARG', 'RUNX2']",0.3507464158071259,0,0,3
108,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.10321122495665487,2.3611099450065067,5.362027944736634,"['MAPK10', 'PIK3CA', 'AKT3', 'EIF4G3']",0.35376560901126797,0,0,4
109,RANKL/RANK signaling pathway WP2018,0.10321122495665487,2.3611099450065067,5.362027944736634,"['MITF', 'TAB2', 'FOS', 'NFKB1']",0.35376560901126797,0,0,4
110,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.10510796226754432,4.028016009148085,9.07418252774735,"['CDH2', 'RUNX2']",0.35376560901126797,0,0,2
111,Transcription co-factors SKI and SKIL protein partners WP4533,0.10510796226754432,4.028016009148085,9.07418252774735,"['NF1', 'TEAD1']",0.35376560901126797,0,0,2
112,GDNF/RET signaling axis WP4830,0.10510796226754432,4.028016009148085,9.07418252774735,"['SLIT2', 'GLI3']",0.35376560901126797,0,0,2
113,Tumor suppressor activity of SMARCB1 WP4204,0.10706064483235742,2.790642347343378,6.235299163429307,"['CDK6', 'ARID1B', 'GLI3']",0.35376560901126797,0,0,3
114,Nuclear receptors WP170,0.10706064483235742,2.790642347343378,6.235299163429307,"['NR4A1', 'ROR1', 'PPARG']",0.35376560901126797,0,0,3
115,PDGFR-beta pathway WP3972,0.10706064483235742,2.790642347343378,6.235299163429307,"['PIK3CA', 'RASA1', 'FOS']",0.35376560901126797,0,0,3
116,Androgen receptor signaling pathway WP138,0.10830625189223128,1.912462503408781,4.251007116149594,"['NCOA1', 'NCOA2', 'ROCK2', 'NCOA3', 'RUNX2', 'PLPP1']",0.3547963424055852,0,0,6
117,Exercise-induced Circadian Regulation WP410,0.10968419449790895,2.3047291205638882,5.093797069058503,"['CRY1', 'TAB2', 'ERC2', 'QKI']",0.35623926418124274,0,0,4
118,let-7 inhibition of ES cell reprogramming WP3299,0.11480424256722516,12.071917808219178,26.129990101565408,['EGR1'],0.3661276745126544,0,0,1
119,Nanomaterial-induced inflammasome activation WP3890,0.11480424256722516,12.071917808219178,26.129990101565408,['NFKB1'],0.3661276745126544,0,0,1
120,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.11561926563557506,2.687094310805651,5.7972788192576585,"['PIK3CA', 'PLCB1', 'NFKB1']",0.3661276745126544,0,0,3
121,MAPK pathway in congenital thyroid cancer WP4928,0.11820134182199202,3.7179047367726614,7.939086704143071,"['BRAF', 'FOS']",0.3712108255566692,0,0,2
122,T-cell receptor (TCR) signaling pathway WP69,0.12218401925040825,1.984313171283211,4.171476757196457,"['VAV3', 'ITPR1', 'CBLB', 'FOS', 'NFKB1']",0.3774112887909116,0,0,5
123,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.12315526265808695,2.1996557659208262,4.6067597948554,"['PPARG', 'LEMD3', 'JUNB', 'RUNX2']",0.3774112887909116,0,0,4
124,PPAR signaling pathway WP3942,0.12315526265808695,2.1996557659208262,4.6067597948554,"['ACADL', 'ME1', 'PPARG', 'CPT1B']",0.3774112887909116,0,0,4
125,miRNA regulation of prostate cancer signaling pathways WP3981,0.12442509700247695,2.5909425625920472,5.399657409162046,"['PIK3CA', 'AKT3', 'NFKB1']",0.3782522948875299,0,0,3
126,Nuclear Receptors Meta-Pathway WP2882,0.12758825843968458,1.4858425045410835,3.0592708643817725,"['NCOA1', 'TGFBR3', 'EGR1', 'NCOA2', 'FGD4', 'NAV3', 'NCOA3', 'SLC2A13', 'ME1', 'SMARCA1', 'JUNB', 'SLC5A3']",0.3847899857704773,0,0,12
127,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.13167252935525908,3.4520950747365844,6.998906238240082,"['ITPR1', 'NFKB1']",0.3939807964960508,0,0,2
128,7q11.23 copy number variation syndrome WP4932,0.14374357195919593,1.750296522879081,3.3950927275818024,"['GRIP1', 'UBE2E1', 'HSPA2', 'ACACB', 'PRKG1', 'FBN1']",0.42197633094830234,0,0,6
129,Apoptosis Modulation by HSP70 WP384,0.14547078777428318,3.221726700971984,6.210780247532209,"['MAPK10', 'NFKB1']",0.42197633094830234,0,0,2
130,Constitutive Androstane Receptor Pathway WP2875,0.14547078777428318,3.221726700971984,6.210780247532209,"['NCOA1', 'NCOA2']",0.42197633094830234,0,0,2
131,"GPCRs, Class B Secretin-like WP334",0.14547078777428318,3.221726700971984,6.210780247532209,"['ADGRL2', 'ADGRL3']",0.42197633094830234,0,0,2
132,Endoderm differentiation WP2853,0.14920905867313547,1.646000604696476,3.131362871711846,"['VAV3', 'SESN1', 'UBR5', 'LAMC1', 'ASCC3', 'TOX', 'TRERF1']",0.4255709435106347,0,0,7
133,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.15006975376427642,8.047374429223744,15.26309349432613,['NFKB1'],0.4255709435106347,0,0,1
134,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.15006975376427642,8.047374429223744,15.26309349432613,['SLIT2'],0.4255709435106347,0,0,1
135,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.15218839952909854,2.339707349517792,4.4048174144892265,"['MAPK10', 'FOS', 'JUNB']",0.42838216163746257,0,0,3
136,ESC Pluripotency Pathways WP3931,0.15474021073318237,1.7088692471807376,3.188763050508294,"['AKT3', 'GAB1', 'BRAF', 'FOS', 'FGF12', 'FGFR2']",0.432362353519186,0,0,6
137,miRNAs involvement in the immune response in sepsis WP4329,0.15954881011045716,3.020154373927959,5.543207598631012,"['TAB2', 'NFKB1']",0.442544144831925,0,0,2
138,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.16184546337914002,2.266430412371134,4.127426632741142,"['RICTOR', 'NFKB1', 'IGF1R']",0.4456614208990812,0,0,3
139,TGF-beta Signaling Pathway WP366,0.16954277845738833,1.5840151343660058,2.8110724641024554,"['TGFBR3', 'SMURF1', 'WWP1', 'FOSB', 'FOS', 'JUNB', 'RUNX2']",0.45621514609938524,0,0,7
140,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.16954277845738833,1.5840151343660058,2.8110724641024554,"['TJP1', 'FMNL2', 'CDH2', 'COL4A2', 'PIK3CA', 'COL4A1', 'AKT3']",0.45621514609938524,0,0,7
141,G13 Signaling Pathway WP524,0.17168096287424234,2.1975945017182132,3.8724194911070895,"['MAPK10', 'PIK3CA', 'ROCK2']",0.45621514609938524,0,0,3
142,Glycogen Synthesis and Degradation WP500,0.17168096287424234,2.1975945017182132,3.8724194911070895,"['GYS2', 'PPP2R2B', 'PHKA1']",0.45621514609938524,0,0,3
143,Hedgehog Signaling Pathway WP4249,0.17168096287424234,2.1975945017182132,3.8724194911070895,"['SMURF1', 'FBXL17', 'GLI3']",0.45621514609938524,0,0,3
144,3q29 copy number variation syndrome WP4906,0.17522186040494164,1.896797273126118,3.303656238226819,"['DYNC2H1', 'DLG1', 'CEP350', 'PXN']",0.46239102051304043,0,0,4
145,Tgif disruption of Shh signaling WP3674,0.18393262277841343,6.035102739726027,10.218550073270851,['GLI3'],0.4659626443719807,0,0,1
146,The alternative pathway of fetal androgen synthesis WP4524,0.18393262277841343,6.035102739726027,10.218550073270851,['HSD17B6'],0.4659626443719807,0,0,1
147,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.18393262277841343,6.035102739726027,10.218550073270851,['PPARG'],0.4659626443719807,0,0,1
148,EV release from cardiac cells and their functional effects WP3297,0.18393262277841343,6.035102739726027,10.218550073270851,['ERBB4'],0.4659626443719807,0,0,1
149,FTO Obesity Variant Mechanism WP3407,0.18393262277841343,6.035102739726027,10.218550073270851,['ARID5B'],0.4659626443719807,0,0,1
150,Metastatic brain tumor WP2249,0.18393262277841343,6.035102739726027,10.218550073270851,['CDK6'],0.4659626443719807,0,0,1
151,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.18554476042987547,1.540484429065744,2.5948830610454703,"['MAPK10', 'RPS6KA6', 'PIK3CA', 'CBLB', 'RICTOR', 'MAP4K5', 'MAP4K3']",0.4669338341943886,0,0,7
152,IL-6 signaling pathway WP364,0.19183316302460116,2.0717231222385863,3.4206825979682054,"['NCOA1', 'GAB1', 'JUNB']",0.4764483787539114,0,0,3
153,PDGF Pathway WP2526,0.19183316302460116,2.0717231222385863,3.4206825979682054,"['RASA1', 'FOS', 'NFKB1']",0.4764483787539114,0,0,3
154,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.19951106670599134,1.7910371645311405,2.8869469643881844,"['RYR2', 'CACNB4', 'CDH2', 'ITGA10']",0.4883141407187325,0,0,4
155,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.19951106670599134,1.7910371645311405,2.8869469643881844,"['PIK3CA', 'RASA1', 'PXN', 'NFKB1']",0.4883141407187325,0,0,4
156,Angiogenesis WP1539,0.2030358795619993,2.5427462309289517,4.054084840387404,"['PIK3CA', 'FGFR2']",0.4883141407187325,0,0,2
157,TLR4 Signaling and Tolerance WP3851,0.2030358795619993,2.5427462309289517,4.054084840387404,"['TAB2', 'NFKB1']",0.4883141407187325,0,0,2
158,Microglia Pathogen Phagocytosis Pathway WP3937,0.2030358795619993,2.5427462309289517,4.054084840387404,"['VAV3', 'PIK3CA']",0.4883141407187325,0,0,2
159,Regulatory circuits of the STAT3 signaling pathway WP4538,0.21623443214256996,1.726825670027047,2.6444472338014964,"['GHR', 'PTPRD', 'MAPK10', 'RICTOR']",0.49862861479149473,0,0,4
160,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.21644854436139743,4.8277397260273975,7.388384608959068,['IGF1R'],0.49862861479149473,0,0,1
161,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.21644854436139743,4.8277397260273975,7.388384608959068,['RUNX2'],0.49862861479149473,0,0,1
162,Peroxiredoxin 2 induced ovarian failure WP4873,0.21644854436139743,4.8277397260273975,7.388384608959068,['MAPK10'],0.49862861479149473,0,0,1
163,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.21644854436139743,4.8277397260273975,7.388384608959068,['NFKB1'],0.49862861479149473,0,0,1
164,1q21.1 copy number variation syndrome WP4905,0.21782197382996873,2.415437392795883,3.6813130188410583,"['TJP1', 'AFDN']",0.49862861479149473,0,0,2
165,Signal Transduction of S1P Receptor WP26,0.21782197382996873,2.415437392795883,3.6813130188410583,"['AKT3', 'PLCB1']",0.49862861479149473,0,0,2
166,Sphingolipid Metabolism (general overview) WP4725,0.21782197382996873,2.415437392795883,3.6813130188410583,"['SGPL1', 'SGPP2']",0.49862861479149473,0,0,2
167,Sphingolipid Metabolism (integrated pathway) WP4726,0.23269636318669554,2.300253205913583,3.3538171058854727,"['SGPL1', 'SGPP2']",0.5285946766095251,0,0,2
168,"GPCRs, Other WP117",0.23369448860631634,1.858710018503833,2.7020822564002174,"['ADGRV1', 'ADGRL2', 'ADGRL3']",0.5285946766095251,0,0,3
169,Neural Crest Differentiation WP2064,0.24198593609145966,1.6386709063858338,2.325070279943485,"['CDH2', 'MITF', 'NFKB1', 'FGFR2']",0.5317230644496117,0,0,4
170,Supression of HMGB1 mediated inflammation by THBD WP4479,0.24767100633574016,4.0228310502283104,5.614480250071239,['NFKB1'],0.5317230644496117,0,0,1
171,Aspirin and miRNAs WP4707,0.24767100633574016,4.0228310502283104,5.614480250071239,['NFKB1'],0.5317230644496117,0,0,1
172,DDX1 as a regulatory component of the Drosha microprocessor WP2942,0.24767100633574016,4.0228310502283104,5.614480250071239,['MRE11'],0.5317230644496117,0,0,1
173,Insulin signaling in adipocytes (diabetic condition) WP3635,0.24767100633574016,4.0228310502283104,5.614480250071239,['TBC1D4'],0.5317230644496117,0,0,1
174,Insulin signaling in adipocytes (normal condition) WP3634,0.24767100633574016,4.0228310502283104,5.614480250071239,['TBC1D4'],0.5317230644496117,0,0,1
175,LDLRAD4 and what we know about it WP4904,0.24767100633574016,4.0228310502283104,5.614480250071239,['LDLRAD4'],0.5317230644496117,0,0,1
176,LTF danger signal response pathway WP4478,0.24767100633574016,4.0228310502283104,5.614480250071239,['NFKB1'],0.5317230644496117,0,0,1
177,Role of Osx and miRNAs in tooth development WP3971,0.24767100633574016,4.0228310502283104,5.614480250071239,['RUNX2'],0.5317230644496117,0,0,1
178,IL-4 signaling pathway WP395,0.2552023585156758,1.767789791299975,2.4142678410525185,"['PIK3CA', 'FOS', 'NFKB1']",0.5438532115676481,0,0,3
179,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.2595231850272112,1.5847182641573319,2.1376411019786987,"['CDK8', 'SEC24B', 'PIK3CA', 'PPARG']",0.5438532115676481,0,0,4
180,Signal transduction through IL1R WP4496,0.2625905806865422,2.0999328809008873,2.8079445441813067,"['IL1RAP', 'NFKB1']",0.5438532115676481,0,0,2
181,Aryl Hydrocarbon Receptor Pathway WP2873,0.2625905806865422,2.0999328809008873,2.8079445441813067,"['NCOA1', 'JUNB']",0.5438532115676481,0,0,2
182,Hematopoietic Stem Cell Differentiation WP2849,0.2625905806865422,2.0999328809008873,2.8079445441813067,"['FOSB', 'FOS']",0.5438532115676481,0,0,2
183,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.2625905806865422,2.0999328809008873,2.8079445441813067,"['FGD4', 'SBF2']",0.5438532115676481,0,0,2
184,Energy Metabolism WP1541,0.26605886815898844,1.7255768286696123,2.2847287509315923,"['NCOA1', 'PPP3CA', 'PPARG']",0.5438532115676481,0,0,3
185,Phosphoinositides metabolism WP4971,0.26605886815898844,1.7255768286696123,2.2847287509315923,"['PIK3CA', 'PLCB1', 'SBF2']",0.5438532115676481,0,0,3
186,Wnt signaling WP428,0.2732665561378909,1.4560656418778561,1.8889649709648288,"['PPP3CA', 'CAMK2D', 'ROCK2', 'ROR1', 'PLCB1']",0.5438532115676481,0,0,5
187,16p11.2 proximal deletion syndrome WP4949,0.27729743742683455,1.5341911865147666,1.9678526748073089,"['PPP4R1', 'PPP4R4', 'PPARG', 'NFKB1']",0.5438532115676481,0,0,4
188,Endothelin Pathways WP2197,0.27755624393392575,2.012292738707833,2.5792193636825935,"['NPY1R', 'PLCB1']",0.5438532115676481,0,0,2
189,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.2776513764319046,3.4478962818003915,4.4180963475096,['CAMK2D'],0.5438532115676481,0,0,1
190,Autosomal recessive Osteopetrosis pathways WP4788,0.2776513764319046,3.4478962818003915,4.4180963475096,['NFKB1'],0.5438532115676481,0,0,1
191,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.2776513764319046,3.4478962818003915,4.4180963475096,['NFKB1'],0.5438532115676481,0,0,1
192,Canonical NF-KB pathway WP4562,0.2776513764319046,3.4478962818003915,4.4180963475096,['NFKB1'],0.5438532115676481,0,0,1
193,HIF1A and PPARG regulation of glycolysis WP2456,0.2776513764319046,3.4478962818003915,4.4180963475096,['PPARG'],0.5438532115676481,0,0,1
194,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.2776513764319046,3.4478962818003915,4.4180963475096,['NFKB1'],0.5438532115676481,0,0,1
195,Ciliary landscape WP4352,0.2857461086267616,1.2599637681159421,1.578295623147723,"['MKLN1', 'TBC1D4', 'WNK1', 'LCA5', 'BBS9', 'IFT57', 'EXOC2', 'NFKB1', 'EHBP1', 'RPGR']",0.5458586331916725,0,0,10
196,Prolactin Signaling Pathway WP2037,0.28625809255829504,1.5101118760757315,1.8889407363573234,"['PIK3CA', 'PXN', 'FOS', 'NFKB1']",0.5458586331916725,0,0,4
197,Genotoxicity pathway WP4286,0.28792109777766806,1.6469072164948453,2.050512795757047,"['ITPR1', 'RAPGEF2', 'CBLB']",0.5458586331916725,0,0,3
198,IL17 signaling pathway WP2112,0.2925016143433393,1.931663807890223,2.374565524119057,"['PIK3CA', 'NFKB1']",0.5458586331916725,0,0,2
199,Intraflagellar transport proteins binding to dynein WP4532,0.2925016143433393,1.931663807890223,2.374565524119057,"['DYNC2H1', 'WDR19']",0.5458586331916725,0,0,2
200,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.2925016143433393,1.931663807890223,2.374565524119057,"['RAP1A', 'TEAD1']",0.5458586331916725,0,0,2
201,Pre-implantation embryo WP3527,0.2925016143433393,1.931663807890223,2.374565524119057,"['EGR1', 'FOSB']",0.5458586331916725,0,0,2
202,Synaptic Vesicle Pathway WP2267,0.29890548602241096,1.6101947308132876,1.944516010226586,"['DNM3', 'SYT1', 'SYN3']",0.5458586331916725,0,0,3
203,Wnt Signaling Pathway WP363,0.29890548602241096,1.6101947308132876,1.944516010226586,"['CDK6', 'PPARG', 'ROR1']",0.5458586331916725,0,0,3
204,Glucocorticoid Receptor Pathway WP2880,0.29890548602241096,1.6101947308132876,1.944516010226586,"['TGFBR3', 'FGD4', 'NAV3']",0.5458586331916725,0,0,3
205,Leptin signaling pathway WP2034,0.30429655301935427,1.4641422834193918,1.741967014846643,"['NCOA1', 'ROCK2', 'ACACB', 'NFKB1']",0.5458586331916725,0,0,4
206,Biotin Metabolism (including IEMs) WP5031,0.3064389859289008,3.016695205479452,3.567955862356531,['ACACB'],0.5458586331916725,0,0,1
207,Blood Clotting Cascade WP272,0.3064389859289008,3.016695205479452,3.567955862356531,['KLKB1'],0.5458586331916725,0,0,1
208,EDA signaling in hair follicle development WP3930,0.3064389859289008,3.016695205479452,3.567955862356531,['BMP1'],0.5458586331916725,0,0,1
209,GABA receptor Signaling WP4159,0.3074045986921524,1.8572371025201213,2.1907792201455707,"['GABRB1', 'GABRA4']",0.5458586331916725,0,0,2
210,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.3074045986921524,1.8572371025201213,2.1907792201455707,"['FOS', 'NFKB1']",0.5458586331916725,0,0,2
211,Peptide GPCRs WP24,0.3074045986921524,1.8572371025201213,2.1907792201455707,"['OPRD1', 'NPY1R']",0.5458586331916725,0,0,2
212,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.3074045986921524,1.8572371025201213,2.1907792201455707,"['PIK3CA', 'RICTOR']",0.5458586331916725,0,0,2
213,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.3074045986921524,1.8572371025201213,2.1907792201455707,"['PIK3CA', 'BRAF']",0.5458586331916725,0,0,2
214,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.3074045986921524,1.8572371025201213,2.1907792201455707,"['CAMK2D', 'ITPR1']",0.5458586331916725,0,0,2
215,Non-small cell lung cancer WP4255,0.3133627000321958,1.4421866570760655,1.673504705202863,"['CDK6', 'PIK3CA', 'AKT3', 'BRAF']",0.5538503535452763,0,0,4
216,Kit receptor signaling pathway WP304,0.3209301706558209,1.5414564597499452,1.7519141559777596,"['MITF', 'FOS', 'JUNB']",0.5591463847484287,0,0,3
217,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.3209301706558209,1.5414564597499452,1.7519141559777596,"['CAMK2D', 'PLCB1', 'NFKB1']",0.5591463847484287,0,0,3
218,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.32224489015764707,1.788323486436694,2.02517529747748,"['PPP3CA', 'NFKB1']",0.5591463847484287,0,0,2
219,Melatonin metabolism and effects WP3298,0.32224489015764707,1.788323486436694,2.02517529747748,"['CRY1', 'NFKB1']",0.5591463847484287,0,0,2
220,IL-1 signaling pathway WP195,0.33195130514076043,1.5092353951890034,1.6643349771018496,"['TAB2', 'IL1RAP', 'NFKB1']",0.5617294684288605,0,0,3
221,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.33408121017084863,2.6813165905631657,2.93971821111867,['NFKB1'],0.5617294684288605,0,0,1
222,Cancer immunotherapy by CTLA4 blockade WP4582,0.33408121017084863,2.6813165905631657,2.93971821111867,['PIK3CA'],0.5617294684288605,0,0,1
223,Transcriptional cascade regulating adipogenesis WP4211,0.33408121017084863,2.6813165905631657,2.93971821111867,['PPARG'],0.5617294684288605,0,0,1
224,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.33408121017084863,2.6813165905631657,2.93971821111867,['GRM5'],0.5617294684288605,0,0,1
225,miR-509-3p alteration of YAP1/ECM axis WP3967,0.33408121017084863,2.6813165905631657,2.93971821111867,['TEAD1'],0.5617294684288605,0,0,1
226,Osteopontin Signaling WP1434,0.33408121017084863,2.6813165905631657,2.93971821111867,['NFKB1'],0.5617294684288605,0,0,1
227,Alpha 6 Beta 4 signaling pathway WP244,0.35166446342977187,1.6647542438043414,1.7397976808279745,"['GAB1', 'LAMC1']",0.5733763493762997,0,0,2
228,MAPK Cascade WP422,0.35166446342977187,1.6647542438043414,1.7397976808279745,"['MAPK10', 'BRAF']",0.5733763493762997,0,0,2
229,Adipogenesis WP236,0.3518010314466731,1.2985724879495737,1.3566050623308648,"['NCOA1', 'NCOA2', 'MBNL1', 'BMP1', 'PPARG']",0.5733763493762997,0,0,5
230,Cancer immunotherapy by PD-1 blockade WP4585,0.3606235460550938,2.413013698630137,2.4610825565852115,['NFKB1'],0.5733763493762997,0,0,1
231,Development and heterogeneity of the ILC family WP3893,0.3606235460550938,2.413013698630137,2.4610825565852115,['TOX'],0.5733763493762997,0,0,1
232,Ganglio Sphingolipid Metabolism WP1423,0.3606235460550938,2.413013698630137,2.4610825565852115,['ST8SIA1'],0.5733763493762997,0,0,1
233,Homologous recombination WP186,0.3606235460550938,2.413013698630137,2.4610825565852115,['MRE11'],0.5733763493762997,0,0,1
234,Inflammatory Response Pathway WP453,0.3606235460550938,2.413013698630137,2.4610825565852115,['LAMC1'],0.5733763493762997,0,0,1
235,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.3606235460550938,2.413013698630137,2.4610825565852115,['NFKB1'],0.5733763493762997,0,0,1
236,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.3606235460550938,2.413013698630137,2.4610825565852115,['NFKB1'],0.5733763493762997,0,0,1
237,Neuroinflammation WP4919,0.3606235460550938,2.413013698630137,2.4610825565852115,['FOS'],0.5733763493762997,0,0,1
238,RalA downstream regulated genes WP2290,0.3606235460550938,2.413013698630137,2.4610825565852115,['EXOC2'],0.5733763493762997,0,0,1
239,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.3606235460550938,2.413013698630137,2.4610825565852115,['STAG1'],0.5733763493762997,0,0,1
240,DNA damage response WP707,0.3649426245945792,1.420153628461694,1.4315363453330614,"['MRE11', 'CDK6', 'SESN1']",0.5750422698415516,0,0,3
241,Fatty acid beta-oxidation WP143,0.3662111297411986,1.6091480846197828,1.6164620724863126,"['ACADL', 'CPT1B']",0.5750422698415516,0,0,2
242,Prostaglandin Synthesis and Regulation WP98,0.3662111297411986,1.6091480846197828,1.6164620724863126,"['MITF', 'PPARG']",0.5750422698415516,0,0,2
243,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.3806296855868858,1.5571294195761634,1.5040754203885953,"['PIK3CA', 'NFKB1']",0.5927839365697402,0,0,2
244,Oxidative Damage WP3941,0.3806296855868858,1.5571294195761634,1.5040754203885953,"['MAPK10', 'NFKB1']",0.5927839365697402,0,0,2
245,Cell Differentiation - Index expanded WP2023,0.3861096861942956,2.1934931506849313,2.0874021976017123,['RUNX2'],0.5935195111503522,0,0,1
246,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.3861096861942956,2.1934931506849313,2.0874021976017123,['NFKB1'],0.5935195111503522,0,0,1
247,miRNA regulation of DNA damage response WP1530,0.38679471964707507,1.3663684108150165,1.2978602930764669,"['MRE11', 'CDK6', 'SESN1']",0.5935195111503522,0,0,3
248,Calcium Regulation in the Cardiac Cell WP536,0.3873495756981246,1.207426597582038,1.1451568276052346,"['RYR2', 'CAMK2D', 'ITPR1', 'PRKD1', 'ADCY8', 'RGS7']",0.5935195111503522,0,0,6
249,Vitamin D-sensitive calcium signaling in depression WP4698,0.3949072622381602,1.5083619210977701,1.4014255782068188,"['GRM5', 'ITPR1']",0.6026697174718911,0,0,2
250,Netrin-UNC5B signaling pathway WP4747,0.40903221566159226,1.4625500285877644,1.3074632113702582,"['ARHGEF12', 'PIK3CA']",0.6094570482837712,0,0,2
251,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.41058159042275116,2.0105593607305936,1.789760960583058,['CDK8'],0.6094570482837712,0,0,1
252,Major receptors targeted by epinephrine and norepinephrine WP4589,0.41058159042275116,2.0105593607305936,1.789760960583058,['ADCY8'],0.6094570482837712,0,0,1
253,Matrix Metalloproteinases WP129,0.41058159042275116,2.0105593607305936,1.789760960583058,['MMP16'],0.6094570482837712,0,0,1
254,miRNAs involved in DNA damage response WP1545,0.41058159042275116,2.0105593607305936,1.789760960583058,['CDK6'],0.6094570482837712,0,0,1
255,NOTCH1 regulation of endothelial cell calcification WP3413,0.41058159042275116,2.0105593607305936,1.789760960583058,['SOX6'],0.6094570482837712,0,0,1
256,Phytochemical activity on NRF2 transcriptional activation WP3,0.41058159042275116,2.0105593607305936,1.789760960583058,['PIK3CA'],0.6094570482837712,0,0,1
257,Hepatitis C and Hepatocellular Carcinoma WP3646,0.42299404958222125,1.4194329532842296,1.221276092059236,"['COL4A2', 'NFKB1']",0.6230144916327289,0,0,2
258,NO/cGMP/PKG mediated Neuroprotection WP4008,0.42299404958222125,1.4194329532842296,1.221276092059236,"['CAMK2D', 'NFKB1']",0.6230144916327289,0,0,2
259,Differentiation of white and brown adipocyte WP2895,0.43407955443998764,1.8557692307692308,1.5486903760397124,['PPARG'],0.6271871889246969,0,0,1
260,ERK Pathway in Huntington's Disease WP3853,0.43407955443998764,1.8557692307692308,1.5486903760397124,['NTRK2'],0.6271871889246969,0,0,1
261,Kennedy pathway from sphingolipids WP3933,0.43407955443998764,1.8557692307692308,1.5486903760397124,['SGPL1'],0.6271871889246969,0,0,1
262,Mammalian disorder of sexual development WP4842,0.43407955443998764,1.8557692307692308,1.5486903760397124,['FGFR2'],0.6271871889246969,0,0,1
263,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.43407955443998764,1.8557692307692308,1.5486903760397124,['PIK3CA'],0.6271871889246969,0,0,1
264,Aryl Hydrocarbon Receptor Netpath WP2586,0.45039168117370554,1.3403849818944158,1.0691415567969984,"['NF1', 'NFKB1']",0.643846088575046,0,0,2
265,Integrated Cancer Pathway WP1971,0.45039168117370554,1.3403849818944158,1.0691415567969984,"['MRE11', 'POU2F1']",0.643846088575046,0,0,2
266,Canonical and non-canonical TGF-B signaling WP3874,0.45664227556084475,1.7230919765166341,1.3506541948016386,['BMP1'],0.643846088575046,0,0,1
267,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.45664227556084475,1.7230919765166341,1.3506541948016386,['FGFR2'],0.643846088575046,0,0,1
268,Overview of interferons-mediated signaling pathway WP4558,0.45664227556084475,1.7230919765166341,1.3506541948016386,['PIK3CA'],0.643846088575046,0,0,1
269,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.45664227556084475,1.7230919765166341,1.3506541948016386,['NFKB1'],0.643846088575046,0,0,1
270,IL-18 signaling pathway WP4754,0.45746958925069053,1.090777350213945,0.8530368289299026,"['SLC4A7', 'NR4A1', 'EPB41', 'ZNF219', 'FOS', 'ACACB', 'RUNX2', 'NFKB1']",0.643846088575046,0,0,8
271,Apoptosis WP254,0.4614940787279571,1.2063573883161511,0.9328593464712106,"['MAPK10', 'NFKB1', 'IGF1R']",0.6471134683270248,0,0,3
272,DNA damage response (only ATM dependent) WP710,0.4757448047194094,1.13532449124228,0.8434026976259864,"['MAPK10', 'PIK3CA', 'AKT3', 'NFKB1']",0.6538008207758901,0,0,4
273,Regulation of Microtubule Cytoskeleton WP2038,0.47703647902053764,1.2696578495982667,0.9397528933230863,"['TRIO', 'PIK3CA']",0.6538008207758901,0,0,2
274,BMP Signaling Pathway in Eyelid Development WP3927,0.47830691625183536,1.6081050228310503,1.1859817452922778,['FGFR2'],0.6538008207758901,0,0,1
275,Transcription factor regulation in adipogenesis WP3599,0.47830691625183536,1.6081050228310503,1.1859817452922778,['PPARG'],0.6538008207758901,0,0,1
276,Globo Sphingolipid Metabolism WP1424,0.47830691625183536,1.6081050228310503,1.1859817452922778,['ST8SIA1'],0.6538008207758901,0,0,1
277,Glycosaminoglycan degradation WP4815,0.47830691625183536,1.6081050228310503,1.1859817452922778,['HPSE2'],0.6538008207758901,0,0,1
278,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.47830691625183536,1.6081050228310503,1.1859817452922778,['ACADL'],0.6538008207758901,0,0,1
279,DNA Repair Pathways Full Network WP4946,0.49338405461993834,1.0865952159055607,0.7676440891643668,"['MRE11', 'RAP1A', 'REV1', 'REV3L', 'FANCC']",0.6681607392211162,0,0,5
280,Ebstein-Barr virus LMP1 signaling WP262,0.49910916447665593,1.5074914383561644,1.0476016895634517,['NFKB1'],0.6681607392211162,0,0,1
281,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.49910916447665593,1.5074914383561644,1.0476016895634517,['BRAF'],0.6681607392211162,0,0,1
282,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.49910916447665593,1.5074914383561644,1.0476016895634517,['PPARG'],0.6681607392211162,0,0,1
283,Proteoglycan biosynthesis WP4784,0.49910916447665593,1.5074914383561644,1.0476016895634517,['CSGALNACT1'],0.6681607392211162,0,0,1
284,MECP2 and Associated Rett Syndrome WP3584,0.5023917108764552,1.130637886597938,0.7783030394988091,"['NF1', 'IGF1R', 'GRIA4']",0.6681607392211162,0,0,3
285,ATM Signaling Network in Development and Disease  WP3878,0.5028788721506295,1.2060034305317324,0.8290139323190794,"['MRE11', 'NFKB1']",0.6681607392211162,0,0,2
286,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.5028788721506295,1.2060034305317324,0.8290139323190794,"['FOS', 'JUNB']",0.6681607392211162,0,0,2
287,Complement system WP2806,0.5154870843095382,1.1765050412082165,0.7796028659337577,"['LAMC1', 'KLKB1']",0.6801565695750851,0,0,2
288,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.5154870843095382,1.1765050412082165,0.7796028659337577,"['ADCY8', 'LEMD3']",0.6801565695750851,0,0,2
289,Purine metabolism and related disorders WP4224,0.5190832926104573,1.4187147461724416,0.930238379926716,['GRM5'],0.6825316650241307,0,0,1
290,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.5222356143039153,1.0962199312714778,0.7121443966576904,"['CDK8', 'CDK6', 'ROR1']",0.6843087359844408,0,0,3
291,NRF2 pathway WP2884,0.5270066467598478,1.0600139963306916,0.6789836103964554,"['EGR1', 'SLC2A13', 'ME1', 'SLC5A3']",0.6863746342485921,0,0,4
292,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.538262213173896,1.3398021308980212,0.8298861043207544,['ITPR1'],0.6863746342485921,0,0,1
293,Triacylglyceride synthesis WP325,0.538262213173896,1.3398021308980212,0.8298861043207544,['PLPP1'],0.6863746342485921,0,0,1
294,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.538262213173896,1.3398021308980212,0.8298861043207544,['ACACB'],0.6863746342485921,0,0,1
295,Kallmann's Syndrome WP5074,0.538262213173896,1.3398021308980212,0.8298861043207544,['PIK3CA'],0.6863746342485921,0,0,1
296,Mitochondrial Gene Expression WP391,0.538262213173896,1.3398021308980212,0.8298861043207544,['PPP3CA'],0.6863746342485921,0,0,1
297,Ovarian infertility WP34,0.538262213173896,1.3398021308980212,0.8298861043207544,['EGR1'],0.6863746342485921,0,0,1
298,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.538262213173896,1.3398021308980212,0.8298861043207544,['FOS'],0.6863746342485921,0,0,1
299,Joubert Syndrome WP4656,0.5416395709674623,1.063826561552456,0.6522900402087153,"['MRE11', 'CSPP1', 'BBS9']",0.6883713610957715,0,0,3
300,Alzheimer's disease WP2059,0.5511694364984219,1.0483340803824892,0.6245062503458815,"['PPP3CA', 'ITPR1', 'PLCB1']",0.696899852694251,0,0,3
301,Modulators of TCR signaling and T cell activation WP5072,0.5520180412130777,1.0960548885077186,0.6512479200251557,"['CBLB', 'NFKB1']",0.696899852694251,0,0,2
302,Monoamine Transport WP727,0.5566775327525312,1.269196106705119,0.7434559151083263,['AMPH'],0.7004551736621253,0,0,1
303,Pathways in clear cell renal cell carcinoma WP4018,0.5698727859792369,1.0186583418033976,0.5728344971440816,"['ME1', 'PLOD2', 'ACACB']",0.7074528792165534,0,0,3
304,Toll-like Receptor Signaling related to MyD88 WP3858,0.5743596038127493,1.205650684931507,0.668532812099665,['NFKB1'],0.7074528792165534,0,0,1
305,Fatty Acid Biosynthesis WP357,0.5743596038127493,1.205650684931507,0.668532812099665,['ACACB'],0.7074528792165534,0,0,1
306,NRF2-ARE regulation WP4357,0.5743596038127493,1.205650684931507,0.668532812099665,['PIK3CA'],0.7074528792165534,0,0,1
307,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.5743596038127493,1.205650684931507,0.668532812099665,['SOX6'],0.7074528792165534,0,0,1
308,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.57527089388925,1.0482511745842344,0.5795929903284905,"['VAV3', 'NFKB1']",0.7074528792165534,0,0,2
309,Phosphodiesterases in neuronal function WP4222,0.57527089388925,1.0482511745842344,0.5795929903284905,"['PDE4D', 'ADCY8']",0.7074528792165534,0,0,2
310,EPO Receptor Signaling WP581,0.5913375742095409,1.148157208088715,0.6032053237207464,['RASA1'],0.7202188403834151,0,0,1
311,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.5913375742095409,1.148157208088715,0.6032053237207464,['ERBB4'],0.7202188403834151,0,0,1
312,SARS-CoV-2 mitochondrial interactions WP5038,0.5913375742095409,1.148157208088715,0.6032053237207464,['NFKB1'],0.7202188403834151,0,0,1
313,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.5976307808087886,1.0044311034877074,0.5170631920445288,"['MAPK10', 'NFKB1']",0.72324744174312,0,0,2
314,p53 transcriptional gene network WP4963,0.5976307808087886,1.0044311034877074,0.5170631920445288,"['SESN1', 'FANCC']",0.72324744174312,0,0,2
315,Sleep regulation WP3591,0.6076394351902926,1.095890410958904,0.5459436790759579,['FOS'],0.729402007968033,0,0,1
316,Cannabinoid receptor signaling WP3869,0.6076394351902926,1.095890410958904,0.5459436790759579,['MAPK10'],0.729402007968033,0,0,1
317,DNA IR-double strand breaks and cellular response via ATM WP3959,0.6084748329628065,0.9838624986872966,0.488782620311333,"['MRE11', 'MCPH1']",0.729402007968033,0,0,2
318,B Cell Receptor Signaling Pathway WP23,0.6144645558368799,0.9513022246337494,0.4632880183995533,"['GAB1', 'BRAF', 'NFKB1']",0.7342658214402966,0,0,3
319,Wnt signaling pathway and pluripotency WP399,0.6230000982738485,0.938880706921944,0.44428642719145484,"['MAPK10', 'PPP2R2B', 'PRKD1']",0.7378535372104954,0,0,3
320,Vitamin B12 metabolism WP1533,0.6232920669593922,1.0481685527099465,0.49551126736186785,['NFKB1'],0.7378535372104954,0,0,1
321,Photodynamic therapy-induced unfolded protein response WP3613,0.6232920669593922,1.0481685527099465,0.49551126736186785,['UBE2E1'],0.7378535372104954,0,0,1
322,Wnt signaling in kidney disease WP4150,0.6383212828176652,1.0044235159817352,0.4508993205437798,['MAPK10'],0.7502271606362984,0,0,1
323,Gastric Cancer Network 2 WP2363,0.6383212828176652,1.0044235159817352,0.4508993205437798,['AHCTF1'],0.7502271606362984,0,0,1
324,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.639667368542528,0.9269032853938515,0.4141468524995611,"['ROCK2', 'ERBB4']",0.7502271606362984,0,0,2
325,Trans-sulfuration and one-carbon metabolism WP2525,0.6527518714284878,0.9641780821917808,0.4112780714768306,['AHCYL2'],0.7516536701297739,0,0,1
326,White fat cell differentiation WP4149,0.6527518714284878,0.9641780821917808,0.4112780714768306,['PPARG'],0.7516536701297739,0,0,1
327,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6527518714284878,0.9641780821917808,0.4112780714768306,['TGFBR3'],0.7516536701297739,0,0,1
328,Glycerophospholipid Biosynthetic Pathway WP2533,0.6527518714284878,0.9641780821917808,0.4112780714768306,['PIK3CA'],0.7516536701297739,0,0,1
329,Lipid Metabolism Pathway WP3965,0.6527518714284878,0.9641780821917808,0.4112780714768306,['AKT3'],0.7516536701297739,0,0,1
330,One-carbon metabolism WP241,0.6527518714284878,0.9641780821917808,0.4112780714768306,['AHCYL2'],0.7516536701297739,0,0,1
331,Cardiac Progenitor Differentiation WP2406,0.6666076374116574,0.9270284510010537,0.3759597774369138,['BMP1'],0.7606934000493388,0,0,1
332,Complement and Coagulation Cascades WP558,0.6666076374116574,0.9270284510010537,0.3759597774369138,['KLKB1'],0.7606934000493388,0,0,1
333,Neovascularisation processes WP4331,0.6666076374116574,0.9270284510010537,0.3759597774369138,['NFKB1'],0.7606934000493388,0,0,1
334,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.6774021413983924,0.8677800003101208,0.3379917862660281,"['EGR1', 'RYR2', 'NTRK2', 'NFKB1']",0.7706970470999674,0,0,4
335,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.6872585902341748,0.8452950558213717,0.31702339054114337,"['CDH2', 'VCL']",0.7795769083253326,0,0,2
336,Prion disease pathway WP3995,0.6926852322833376,0.8606898238747553,0.31602773944157825,['NFKB1'],0.7833940127013936,0,0,1
337,Lung fibrosis WP3624,0.7049500935588973,0.8309518186112423,0.29052424509403196,['FAM13A'],0.7948992152889643,0,0,1
338,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.7132570587515955,0.8028587764436821,0.2712967327141659,"['RNF19A', 'HSPA2']",0.8018866340994268,0,0,2
339,IL-2 signaling pathway WP49,0.7280331935811989,0.7772315510384445,0.24670000666273095,['FOS'],0.8160844057842348,0,0,1
340,Amyotrophic lateral sclerosis (ALS) WP2447,0.7388895392382379,0.7528895547945206,0.22782953092518587,['PPP3CA'],0.8233959674795611,0,0,1
341,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.7388895392382379,0.7528895547945206,0.22782953092518587,['NFKB1'],0.8233959674795611,0,0,1
342,ATM Signaling Pathway WP2516,0.7493132305593323,0.7300228310502284,0.21068326371523782,['MRE11'],0.8253305148189747,0,0,1
343,Target Of Rapamycin (TOR) Signaling WP1471,0.7493132305593323,0.7300228310502284,0.21068326371523782,['RICTOR'],0.8253305148189747,0,0,1
344,Bladder cancer WP2828,0.7493132305593323,0.7300228310502284,0.21068326371523782,['BRAF'],0.8253305148189747,0,0,1
345,IL-5 signaling pathway WP127,0.7493132305593323,0.7300228310502284,0.21068326371523782,['FOS'],0.8253305148189747,0,0,1
346,Ebola Virus Pathway on Host WP4217,0.7543016380049086,0.760010851871948,0.21429489465787707,"['PIK3CA', 'NFKB1', 'IGF1R']",0.8284237642828476,0,0,3
347,Metapathway biotransformation Phase I and II WP702,0.7663363035445944,0.744234243809119,0.19806616054450416,"['NDST3', 'HS6ST2', 'HS2ST1']",0.8372312681091104,0,0,3
348,Amino Acid metabolism WP3925,0.7669170183085245,0.7186195949924478,0.1907048775718046,"['PPM1L', 'GLS']",0.8372312681091104,0,0,2
349,Folate Metabolism WP176,0.7689308225528408,0.6882093933463796,0.18082995757589596,['NFKB1'],0.8372312681091104,0,0,1
350,Nephrotic syndrome WP4758,0.7781571271027289,0.669044901065449,0.16781439984558688,['TTC21B'],0.8400559894859005,0,0,1
351,Proximal tubule transport WP4917,0.7781571271027289,0.669044901065449,0.16781439984558688,['SLC4A4'],0.8400559894859005,0,0,1
352,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.7781571271027289,0.669044901065449,0.16781439984558688,['NFKB1'],0.8400559894859005,0,0,1
353,Interleukin-11 Signaling Pathway WP2332,0.7870156383399404,0.6509163272861903,0.15589912090448949,['RUNX2'],0.8472123018956864,0,0,1
354,DNA IR-damage and cellular response via ATR WP4016,0.7934915548926191,0.677940714613582,0.15681608150442566,"['MRE11', 'MCPH1']",0.8515435987796313,0,0,2
355,Metabolic reprogramming in colon cancer WP4290,0.7955209935967609,0.6337418889689979,0.14497355309010737,['GLS'],0.8515435987796313,0,0,1
356,IL-3 signaling pathway WP286,0.8036872487504625,0.617448191078328,0.13494026405108653,['FOS'],0.8578684115875723,0,0,1
357,Histone Modifications WP2369,0.8115279011302667,0.6019691780821917,0.12571314254877386,['SETD5'],0.8638112112871187,0,0,1
358,Pyrimidine metabolism WP4022,0.8173547078858118,0.6416009148084619,0.12939943228375375,"['NME7', 'CTPS1']",0.8675832094877333,0,0,2
359,Cytosolic DNA-sensing pathway WP4655,0.8332232962948698,0.5598518636508443,0.10214699356522834,['NFKB1'],0.8792196066296158,0,0,1
360,TNF-alpha signaling pathway WP231,0.8336014193859907,0.6167920130184281,0.11225608793828122,"['TAB2', 'NFKB1']",0.8792196066296158,0,0,2
361,Senescence and Autophagy in Cancer WP615,0.8387202881706507,0.6089410947304427,0.10709935115345126,"['BRAF', 'IGF1R']",0.8792196066296158,0,0,2
362,Copper homeostasis WP3286,0.8398860979119752,0.5470890410958904,0.09546101644361432,['PIK3CA'],0.8792196066296158,0,0,1
363,Prader-Willi and Angelman Syndrome WP3998,0.8398860979119752,0.5470890410958904,0.09546101644361432,['CDK6'],0.8792196066296158,0,0,1
364,Pathogenic Escherichia coli infection WP2272,0.8583219202511003,0.5120591664237831,0.07823037754765491,['ROCK2'],0.8960503563060938,0,0,1
365,Interferon type I signaling pathways WP585,0.8639835546812759,0.501355593607306,0.07329896202529054,['RAP1A'],0.8972400778555583,0,0,1
366,Vitamin D Receptor Pathway WP2877,0.8665450225604997,0.5657148622742407,0.08103368256151308,"['EFNA5', 'JUNB']",0.8972400778555583,0,0,2
367,"GPCRs, Class A Rhodopsin-like WP455",0.8665450225604997,0.5657148622742407,0.08103368256151308,"['OPRD1', 'NPY1R']",0.8972400778555583,0,0,2
368,Translation Factors WP107,0.8746381858573414,0.4812328767123288,0.06445872805491158,['EIF4G3'],0.8982770557453776,0,0,1
369,G1 to S cell cycle control WP45,0.8746381858573414,0.4812328767123288,0.06445872805491158,['CDK6'],0.8982770557453776,0,0,1
370,Notch Signaling Pathway Netpath WP61,0.8746381858573414,0.4812328767123288,0.06445872805491158,['NFKB1'],0.8982770557453776,0,0,1
371,Selenium Micronutrient Network WP15,0.8796488185407761,0.47176336287939835,0.060495405337213884,['NFKB1'],0.9009880082088813,0,0,1
372,Male infertility WP4673,0.8899023267230356,0.5281887923397357,0.0616098250696749,"['DDX4', 'CDC42BPA']",0.9078470087070734,0,0,2
373,Nonalcoholic fatty liver disease WP4396,0.8924434840070098,0.5717558501063655,0.06506129348196939,"['PIK3CA', 'AKT3', 'NFKB1']",0.9078470087070734,0,0,3
374,AGE/RAGE pathway WP2324,0.8935125822538037,0.4454591577879249,0.05015641261897096,['NFKB1'],0.9078470087070734,0,0,1
375,Acute viral myocarditis WP4298,0.9018574171415822,0.42948874755381605,0.044365691793423485,['RASA1'],0.91388218270347,0,0,1
376,Cell cycle WP179,0.9064082373133523,0.5005002858776444,0.04918190151490209,"['STAG1', 'CDK6']",0.9160508781358349,0,0,2
377,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.919973444943507,0.39414439703570625,0.032875770802830336,['ROR1'],0.9272941885372219,0,0,1
378,Retinoblastoma gene in cancer WP2446,0.94680187577237,0.3383899286127725,0.018498227630139245,['CDK6'],0.9518114095066154,0,0,1
379,Cytoplasmic Ribosomal Proteins WP477,0.9711819762678228,0.27906976744186046,0.008160395457960944,['RPS6KA6'],0.9723365787205608,0,0,1
380,22q11.2 copy number variation syndrome WP4657,0.9723365787205608,0.27584238702566527,0.00773827821796738,['FGFR2'],0.9723365787205608,0,0,1
